Amsterdam Molecular Therapeutics
Pharmaceutical / Biotechnology
Companies / Amsterdam Molecular Therapeutics
0
Latest Hiring Jobs
2
Clinical Trials
0
FDA Products
0
Publications
Company Overview
COMPANY TYPE
Unknown
INDUSTRIES
Unknown
HEADQUARTERS
WEBSITE
Not available
Clinical activity detected
This company has 2 clinical trial records in the intelligence database.
Clinical Development
Recent clinical trial activity
2 Trials
Trial Phase Status Enrollment Start Date Condition
NCT01447901
Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Observational TERMINATED - - Hyperlipoproteinemia Type I
NCT01448577
Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies
Observational UNKNOWN - - Lipoprotein Lipase Deficiency
Company Intelligence
Company profile enrichment is not available yet.

Hiring Intelligence

Latest open positions detected for this company
View All Jobs
No current hiring positions found.
FDA Regulatory Intelligence
FDA product and regulatory signals
0 Signals
No FDA regulatory data available.